GO:0006707 cholesterol catabolic process: Degradation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006707 cholesterol catabolic process describes the biochemical reactions and pathways that break down cholesterol (cholest-5-en-3 beta-ol), the principal sterol of vertebrates and precursor of bile acids and steroid hormones.
• Cholesterol catabolism is essential for maintaining sterol homeostasis, generating bile acids for lipid digestion, and producing steroid hormones.
• Key genes and enzymes include CYP7A1, CYP27A1, CYP11A1, HSD3B7, AKR1D1, and ACAT1, which catalyze oxidative and side-chain cleavage steps.
• In mycobacteria, cholesterol catabolic genes are organized in clusters and are critical for pathogenicity and survival within macrophages.
• Dysregulation of cholesterol catabolism is linked to atherosclerosis, metabolic disorders, and tumor progression.
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of cholesterol catabolic pathways in human cells and model organisms.
Description
Cholesterol is a fundamental sterol in vertebrate biology, serving as a structural component of cell membranes and as the precursor for bile acids, steroid hormones, and vitamin D. The controlled breakdown of cholesterol, defined by the Gene Ontology term GO:0006707 (cholesterol catabolic process), is a tightly regulated metabolic pathway that converts this hydrophobic molecule into water-soluble products for excretion or signaling. This process is central to whole-body cholesterol balance and prevents the accumulation of excess sterols that can contribute to disease. Researchers study cholesterol catabolism to understand metabolic disorders, cardiovascular disease, and host-pathogen interactions, particularly in Mycobacterium tuberculosis where cholesterol degradation supports intracellular survival. The pathway also intersects with cancer metabolism, as altered cholesterol catabolism can influence tumor cell proliferation and immune evasion. Advances in CRISPR gene editing now allow precise manipulation of genes involved in this process, enabling functional studies and therapeutic target validation.
cholesterol catabolic process At A Glance
| GO ID | GO:0006707 |
|---|---|
| GO term | cholesterol catabolic process |
| Ontology | biological_process |
| Synonym | cholesterol breakdown; cholesterol catabolism; cholesterol degradation |
| Major function | Breakdown of cholesterol into bile acids, steroid hormones, and other metabolites |
| Key enzymes | CYP7A1, CYP27A1, CYP11A1, HSD3B7, AKR1D1, ACAT1 |
| Cellular location | Mitochondria, endoplasmic reticulum, peroxisomes, cytosol |
| Pathway relevance | Sterol homeostasis, bile acid biosynthesis, steroidogenesis, host-pathogen interactions |
What Is GO:0006707?
GO:0006707 cholesterol catabolic process is defined as the chemical reactions and pathways resulting in the breakdown of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. This biological process encompasses enzymatic steps that modify the sterol ring and oxidize the side chain, ultimately yielding products such as bile acids, steroid hormones, and metabolic intermediates.
Why Is cholesterol catabolic process Important in Cell Biology?
Cholesterol catabolic process is vital for maintaining sterol homeostasis and preventing the toxic accumulation of cholesterol and its intermediates. It provides the primary route for cholesterol elimination from the body via bile acid synthesis and is indispensable for the production of steroid hormones that regulate development, metabolism, and stress responses. Defects in this pathway are associated with metabolic disorders, atherosclerosis, and certain cancers, making it a target for therapeutic intervention. In infectious disease, cholesterol catabolism is a virulence factor for Mycobacterium tuberculosis, enabling the pathogen to persist in macrophages.
• Maintains cholesterol homeostasis by converting excess cholesterol into excretable bile acids.
• Provides precursors for steroid hormones, including glucocorticoids, mineralocorticoids, and sex hormones.
• Dysregulation contributes to atherosclerosis and cardiovascular disease.
• Altered cholesterol catabolism is observed in tumor metabolism and cancer progression.
• Essential for Mycobacterium tuberculosis survival and pathogenesis within host macrophages.
• Serves as a target for drug development against tuberculosis and metabolic disorders.
• Enables cellular adaptation to changing lipid environments and energy demands.
• Provides a model system for studying enzyme kinetics and metabolic flux.
• CRISPR screens can identify novel regulators of cholesterol catabolism.
• Biomarkers of cholesterol catabolism inform diagnosis and monitoring of metabolic diseases.
What Happens During cholesterol catabolic process?
Initiation of Cholesterol Catabolism
In simple terms: The body starts breaking down cholesterol by modifying it chemically.
Cholesterol catabolism begins with enzymatic modifications of the sterol ring or side chain. The classic pathway involves hydroxylation of cholesterol by cytochrome P450 enzymes such as CYP7A1 (cholesterol 7-alpha-hydroxylase) in the liver, which is the rate-limiting step in bile acid synthesis. Alternatively, CYP27A1 initiates an acidic pathway by 27-hydroxylation of cholesterol. These initial oxidations increase cholesterol solubility and commit it to degradation.
Bile Acid Synthesis
In simple terms: Cholesterol is converted into bile acids, which help digest fats.
The majority of cholesterol catabolism occurs in the liver through bile acid synthesis. Following initial hydroxylation, a series of enzymatic reactions including those catalyzed by HSD3B7, AKR1D1, and CYP8B1 modify the sterol nucleus and oxidize the side chain, eventually producing cholic acid and chenodeoxycholic acid. These bile acids are conjugated with glycine or taurine and secreted into bile, facilitating intestinal lipid absorption and providing a route for cholesterol elimination.
Steroid Hormone Biosynthesis
In simple terms: Cholesterol is also broken down into hormones like cortisol and testosterone.
In steroidogenic tissues, cholesterol catabolism proceeds via side-chain cleavage catalyzed by CYP11A1 (P450scc), converting cholesterol to pregnenolone, the precursor of all steroid hormones. Subsequent reactions catalyzed by enzymes such as HSD3B2, CYP17A1, and CYP21A2 yield glucocorticoids, mineralocorticoids, and sex steroids. This branch of cholesterol catabolism is critical for endocrine function and stress responses.
Microbial Cholesterol Degradation
In simple terms: Some bacteria break down cholesterol to survive inside cells.
Mycobacterium tuberculosis and related species possess a large repertoire of cholesterol catabolic genes organized in clusters, enabling them to degrade cholesterol as a carbon and energy source. This pathway involves ring-opening enzymes, side-chain oxidation, and beta-oxidation steps that convert cholesterol into propionyl-CoA and acetyl-CoA. Cholesterol catabolism is essential for mycobacterial survival in macrophages and represents a potential drug target.
Regulation of Cholesterol Catabolism
In simple terms: The breakdown of cholesterol is turned on or off depending on the body's needs.
Cholesterol catabolism is transcriptionally regulated by nuclear receptors and transcription factors. The farnesoid X receptor (FXR) senses bile acid levels and inhibits CYP7A1 expression via small heterodimer partner (SHP), providing feedback control. Liver X receptors (LXRs) promote cholesterol efflux and catabolism in response to oxysterols. Hormonal signals such as glucocorticoids and thyroid hormone also modulate pathway activity.
Key Genes Involved in GO:0006707 cholesterol catabolic process
The following genes and enzymes are central to cholesterol catabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP7A1 | Rate-limiting enzyme in bile acid synthesis | Target for hypercholesterolemia and bile acid disorders |
| CYP27A1 | Mitochondrial sterol 27-hydroxylase in acidic bile acid pathway | Mutations cause cerebrotendinous xanthomatosis |
| CYP11A1 | Side-chain cleavage enzyme initiating steroidogenesis | Essential for steroid hormone production |
| HSD3B7 | 3-beta-hydroxysteroid dehydrogenase in bile acid synthesis | Defects cause bile acid synthesis disorders |
| AKR1D1 | Delta-4-3-oxosteroid 5-beta-reductase | Required for bile acid synthesis |
| CYP8B1 | Sterol 12-alpha-hydroxylase | Determines cholic acid synthesis ratio |
| ACAT1 | Acyl-CoA cholesterol acyltransferase | Regulates cholesterol esterification and storage |
| NR1H4 (FXR) | Nuclear receptor regulating bile acid homeostasis | Drug target for metabolic liver diseases |
| NR1H2/3 (LXR) | Oxysterol sensors promoting cholesterol catabolism | Linked to reverse cholesterol transport |
| SHP (NR0B2) | Small heterodimer partner inhibiting CYP7A1 | Feedback regulator of bile acid synthesis |
| CYP17A1 | Steroid 17-alpha-hydroxylase | Involved in sex steroid synthesis |
| CYP21A2 | Steroid 21-hydroxylase | Defects cause congenital adrenal hyperplasia |
| HSD3B2 | 3-beta-hydroxysteroid dehydrogenase type 2 | Required for cortisol and aldosterone synthesis |
| CYP46A1 | Cholesterol 24-hydroxylase in brain | Produces 24S-hydroxycholesterol for brain cholesterol turnover |
| CH25H | Cholesterol 25-hydroxylase | Generates 25-hydroxycholesterol with immune functions |
| Mce4 | Mycobacterial cholesterol uptake system | Required for cholesterol import in M. tuberculosis |
| KshA/KshB | Mycobacterial cholesterol ring-degrading enzymes | Targets for anti-tuberculosis drug development |
How Is cholesterol catabolic process Regulated?
Cholesterol catabolic process is regulated at multiple levels. Transcriptional control is mediated by nuclear receptors such as FXR, which suppresses CYP7A1 via SHP in response to bile acid levels, and LXRs, which induce genes involved in cholesterol efflux and catabolism. Hormonal regulation by glucocorticoids and thyroid hormone modulates enzyme expression. In mycobacteria, cholesterol catabolic genes are regulated by KstR, a TetR-family repressor that senses cholesterol metabolites. Post-translational modifications and substrate availability also influence pathway flux.
cholesterol catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP7A1 | Hypercholesterolemia, bile acid diarrhea | Hepatocyte knockout or overexpression |
| CYP27A1 | Cerebrotendinous xanthomatosis | Patient-derived fibroblasts or knock-in mice |
| HSD3B7 | Bile acid synthesis defect, cholestasis | CRISPR knockout HepG2 cells |
| CYP11A1 | Adrenal insufficiency, disordered steroidogenesis | Steroidogenic cell line knockout |
| Mce4 | M. tuberculosis virulence | Mycobacterial knockout and macrophage infection |
Atherosclerosis and Cardiovascular Disease
Impaired cholesterol catabolism leads to cholesterol accumulation in arterial walls, promoting atherosclerosis. Reduced bile acid synthesis and defective reverse cholesterol transport contribute to plaque formation. Exercise and metabolic interventions can enhance cholesterol catabolic pathways, as shown by resistance training-induced antiatherogenic metabolomic changes.
Metabolic Disorders and Liver Disease
Defects in bile acid synthesis enzymes such as HSD3B7 and AKR1D1 cause cholestatic liver disease and fat-soluble vitamin malabsorption. Dysregulation of FXR signaling is implicated in non-alcoholic fatty liver disease and metabolic syndrome.
Cancer Metabolism
Altered cholesterol catabolism is observed in multiple cancers. Tumor cells can reprogram cholesterol metabolism to support proliferation and survival, and bile acid receptors such as FXR and TGR5 influence tumor progression. Targeting cholesterol catabolic enzymes is being explored as an anticancer strategy.
Tuberculosis and Infectious Disease
Mycobacterium tuberculosis relies on cholesterol catabolism for survival within macrophages. Genes encoding cholesterol degradation enzymes are essential for virulence, and their inhibition impairs bacterial persistence. This makes the mycobacterial cholesterol catabolic pathway an attractive target for new anti-tuberculosis drugs.
From cholesterol catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CYP7A1 affect bile acid synthesis? | CYP7A1 knockout hepatocytes or mouse model |
| Can a point mutation in CYP27A1 alter enzyme activity? | CRISPR knock-in of patient mutation in HepG2 cells |
| Does overexpression of CYP11A1 increase steroid production? | CYP11A1 overexpression in adrenal cell lines |
| What genes regulate cholesterol catabolism in macrophages? | CRISPR library screening in THP-1 cells |
| How does mycobacterial cholesterol catabolism affect virulence? | Mce4 knockout M. tuberculosis in macrophage infection model |
| Can tagged CYP46A1 track cholesterol turnover in neurons? | Knock-in of fluorescent tag in neuronal cells |
How to Study the cholesterol catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isotope tracing + mass spectrometry | Metabolic flux from cholesterol to products | Quantifying bile acid synthesis |
| RNA-seq | Expression of cholesterol catabolic genes | Transcriptional regulation studies |
| CRISPR knockout screening | Genes affecting cholesterol catabolism | Discovery of novel regulators |
| Enzymatic activity assay | Catalytic activity of enzymes like CYP7A1 | Functional validation of variants |
| Western blot | Protein expression levels | Confirming knockout or overexpression |
| Immunofluorescence | Subcellular localization of enzymes | Mitochondrial vs ER localization |
| Cholesterol efflux assay | Cellular cholesterol removal | Macrophage foam cell studies |
| Metabolomics | Global metabolite changes | Pathway discovery and biomarker identification |
Metabolic Flux Analysis
Isotope tracing with labeled cholesterol (e.g., 13C-cholesterol) coupled with mass spectrometry measures the conversion of cholesterol to bile acids and steroids, providing quantitative flux data. This method is essential for assessing pathway activity in cells and animal models.
Gene Expression Profiling
RNA-seq and qPCR quantify expression of cholesterol catabolic genes such as CYP7A1, CYP27A1, and HSD3B7 under different conditions. This reveals transcriptional regulation and identifies candidate regulators.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate cholesterol catabolism, using reporters or metabolite readouts. This approach uncovers novel pathway components and therapeutic targets.
Protein and Enzyme Assays
Western blotting, immunoprecipitation, and enzymatic activity assays measure protein levels and catalytic activity of cholesterol catabolic enzymes. These methods validate functional changes observed in genetic models.
How CRISPR Can Be Used to Study GO:0006707 cholesterol catabolic process
Knockout
CRISPR knockout of genes such as CYP7A1, CYP27A1, or HSD3B7 in hepatocyte or steroidogenic cell lines abolishes specific enzymatic steps, allowing researchers to measure the impact on cholesterol catabolism and downstream products. Knockout models are also used to study mycobacterial cholesterol degradation genes.
Point Mutation
CRISPR-mediated point mutations can recreate patient-derived missense variants in cholesterol catabolic enzymes, enabling functional assessment of enzyme activity, stability, and substrate specificity. This is particularly useful for variants of uncertain significance in genes like CYP27A1.
Knock-in
Knock-in of reporter tags (e.g., GFP, HA) or regulatory elements allows real-time tracking of enzyme expression and localization. Knock-in of disease-associated mutations into model cell lines provides isogenic systems for mechanistic studies.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of cholesterol catabolic genes such as CYP11A1 or CYP46A1 increases pathway flux, enabling studies of steroidogenesis and brain cholesterol turnover. Overexpression models help identify rate-limiting steps and potential toxic intermediates.
How EDITGENE Supports cholesterol catabolic process Research
Researchers studying cholesterol catabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, metabolite production, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for cholesterol catabolic process research.
Frequently Asked Questions About cholesterol catabolic process
What is cholesterol catabolic process?
Cholesterol catabolic process (GO:0006707) is the set of biochemical reactions that break down cholesterol into products such as bile acids and steroid hormones.
What genes are involved in cholesterol catabolic process?
Key genes include CYP7A1, CYP27A1, CYP11A1, HSD3B7, AKR1D1, and ACAT1, among others.
Where does cholesterol catabolism occur in the cell?
It occurs in multiple compartments including the endoplasmic reticulum, mitochondria, peroxisomes, and cytosol.
Why is cholesterol catabolism important?
It maintains cholesterol homeostasis, produces bile acids for digestion, and generates steroid hormones.
How is cholesterol catabolic process regulated?
It is regulated by nuclear receptors such as FXR and LXR, hormones, and feedback mechanisms.
What diseases are linked to defective cholesterol catabolism?
Defects are linked to atherosclerosis, bile acid synthesis disorders, cerebrotendinous xanthomatosis, and some cancers.
Can CRISPR be used to study cholesterol catabolism?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise functional studies of cholesterol catabolic genes.
What is the role of cholesterol catabolism in tuberculosis?
Mycobacterium tuberculosis uses cholesterol catabolism for survival in macrophages, making it a virulence factor and drug target.
How can I measure cholesterol catabolic flux?
Isotope tracing with mass spectrometry and metabolite profiling are standard methods to quantify pathway flux.
What services does EDITGENE offer for cholesterol catabolism research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
Cholesterol catabolic process (GO:0006707) is a fundamental biological pathway that governs sterol homeostasis, bile acid synthesis, and steroid hormone production. Its dysregulation is implicated in cardiovascular disease, metabolic disorders, cancer, and infectious diseases such as tuberculosis. Advances in CRISPR gene editing and metabolic profiling now allow researchers to dissect the pathway with unprecedented precision, identifying new therapeutic targets and biomarkers. Continued investigation of cholesterol catabolism will deepen our understanding of human physiology and disease.
References
- 1. Schade DS et al.. 2020. Cholesterol Review: A Metabolically Important Molecule.. Endocr Pract 26(12):1514-1523 PMID: 33471744
- 2. Cui D et al.. 2025. Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets.. Mol Biomed 6(1):72 PMID: 41062796
- 3. Sarin HV et al.. 2019. Resistance Training Induces Antiatherogenic Effects on Metabolomic Pathways.. Med Sci Sports Exerc 51(9):1866-1875 PMID: 30973481
- 4. Weis HJ. 1970. [Cholesterol metabolism].. Klin Wochenschr 48(20):1203-9 PMID: 4920502
- 5. Lichtenstein AH. 1990. Intestinal cholesterol metabolism.. Ann Med 22(1):49-52 PMID: 2184845
- 6. Meng Y et al.. 2021. Cholesterol metabolism and tumor.. Zhejiang Da Xue Xue Bao Yi Xue Ban 50(1):23-31 PMID: 34117857
- 7. Robichaud S et al.. 2019. Quantifying Cellular Cholesterol Efflux.. Methods Mol Biol 1951:111-133 PMID: 30825148
- 8. van Wyk R et al.. 2019. Comprehensive Comparative Analysis of Cholesterol Catabolic Genes/Proteins in Mycobacterial Species.. Int J Mol Sci 20(5) PMID: 30818787
